4/2
08:01 am
tvrd
Tvardi Therapeutics (TVRD) had its "buy" rating reaffirmed by BTIG Research. They now have a $15.00 price target on the stock.
Low
Report
Tvardi Therapeutics (TVRD) had its "buy" rating reaffirmed by BTIG Research. They now have a $15.00 price target on the stock.
4/1
03:04 pm
tvrd
Rating for TVRD
Medium
Report
Rating for TVRD
4/1
03:04 pm
tvrd
Rating for TVRD
Medium
Report
Rating for TVRD